🔎 Trials Near Me

Home › Cholesterol › California

Cholesterol clinical trials in California

7 studies for Cholesterol are looking for participants at sites in California.

Cities in California

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  • Pacific Oaks Medical Group, Beverly Hills
  • Cardiovascular Institute of San Diego, Chula Vista
  • John Muir Medical Center - Concord Campus, Concord
  • and 12 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06909565

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

  • Clinical Study Center, Garden Grove
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Oct 23, 2026 · NCT06451770

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia

  • Research Site, Gardena
  • Research Site, Lomita
  • Research Site, Pomona
  • and 1 more
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Oct 5, 2026 · NCT07619118

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

  • Research Site, Huntington Beach
  • Research Site, Loma Linda
  • Research Site, Lomita
  • and 2 more
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 10, 2026 · NCT07619131

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

  • Clinical Trials Research, Lincoln
  • Downtown L A Research Center Inc, Los Angeles
  • Valley Clinical Trials, Northridge
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07610278

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

  • UC San Francisco Medical Center, San Francisco
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Jul 24, 2026 · NCT06597006

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  • UC San Francisco Medical Center, San Francisco
  • UC San Francisco Medical Center, San Francisco
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated May 15, 2026 · NCT06597019

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.